Adrenocortical carcinoma (ACC) is a disease that most physicians, including many
endocrinologists, will rarely, if ever, diagnose or let alone treat during the course
of their medical practice. Medical textbooks of endocrinology and oncology rarely
dedicate an entire chapter to this disease entity. The pursuit of research and clinical
excellence in uncommon diseases is extremely challenging because of a lack of
research prioritization, nonexistent treatment guidelines and overall paucity of coordination
between researchers and physicians.
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature
This book accompanies the fourth annual ICMCC Event.
In the past 12 months the role of ICMCC with regards to patient-related ICT has
become obvious with the start of the Record Access Portal. It is our goal to come forward
with a recommendation to the WHO on Record Access. This recommendation
will therefore be one of the leading issues of the Round Table on the Responsibility
Shift from Doctor to Patient.
The type of cancer that develops in the cortex of the adrenal gland is called adrenal
cortical carcinoma. It is also known as adrenocortical cancer (or carcinoma) or just
adrenal cancer. In this document, the term adrenal cancer is used to mean cancer that
starts in the adrenal cortex.
Adrenal cancer most often is discovered for 1 of 2 reasons. The first is that it produces
hormones that cause body changes such as weight gain and fluid retention, early puberty
in children, or excess facial or body hair growth in women.
The second reason an adrenal cancer may be...